Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Military myositis mystery: could exposures be the trigger?

NCT ID NCT01734369

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 17 times

Summary

This study investigated whether environmental exposures during military service increase the risk of developing myositis, a rare autoimmune disease that attacks muscles. Researchers compared 37 military personnel with and without myositis using questionnaires and blood samples. No treatment was given; the goal was to identify potential risk factors for future prevention.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study identifies specific environmental triggers, it could point toward ways to reduce the risk of myositis in military personnel.
What could go wrong
This is a small, observational study that only looks for patterns, not causes. It cannot prove that any factor directly causes myositis, and results may not apply to the general public.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

37 people

The number who actually took part.

Started

Mar 2014

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Myositis patients include diagnosis of myositis during military service or service as a military contractor based on criteria for probable or definite PM or DM, or clinically or pathologically defined or possible IBM. Subjects may be active duty or no longer active duty personnel. Military contractors include those with at least 1 year of collective service on a military base or who actively deployed with military units after October 1998 and developed myositis will be eligible for this study. Control subjects include persons with military experience or having served as a military contractor attending the same clinic or hospital as the myositis subject to which they are matched, or if not available, volunteers from the general community (such as other participating military or VA hospitals, private HCPs, or the NIH healthy volunteer program), matched to the myositis subject.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* ELIGIBILITY CRITERIA: For Aim 1 of the study: The inclusion criteria for myositis subjects are: -Diagnosis of PM, DM or IBM during military service. Subjects may be active duty or no longer active duty personnel. A matrix diagnosis of myositis will be based on ICD-9 codes, laboratory tests and medical records in an attempt to match criteria for probable or definite PM, DM or IBM The inclusion criteria for matched control subjects are: -The same gender, race, age within 10 years, and service in the military within 10 years as the myositis subject. The exclusion criteria for control subjects are: -A matrix diagnosis of autoimmune or chronic muscle disease based on ICD-9 codes and medical records. For Aims 2 and 3 of the study: The inclusion criteria for enrollment of myositis subjects are: * Diagnosis of myositis during military service or service as a military contractor or civilian working for the military, based on criteria for probable or definite PM or DM, or clinically or pathologically defined or possible IBM. Subjects may be active duty or no longer active duty personnel. Military contractors or civilians working for the military include those with at least 1 year of collective service on a military base or who actively deployed with military units after October 1998 and developed myositis will be eligible for this study. * Able and willing to give informed consent, to complete the questionnaires and to donate blood samples. The inclusion criteria for matched controls are: * Persons with military experience or having served as a military contractor or civilian working for the military attending the same clinic or hospital as the myositis subject to which they are matched, or if not available, volunteers from the general community (such as other participating military or VA hospitals, private HCPs, or the NIH healthy volunteer program), gender- race- and age- (within 10 years) and military service period (within 10 years) matched to the myositis subject. Military contractors include those with at least 1 year of collective service on a military base or who actively deployed with military units after October 1998. * Controls should be without a recognized autoimmune or chronic muscle disease, able and willing to give informed consent, to complete the questionnaires and to donate blood samples. The exclusion criteria for all protocol subjects are: * Medical illness that in the judgment of the investigators does not allow safe blood draws or other clinical evaluations needed for study participation. * Chronic muscle diseases other than idiopathic inflammatory myopathy (e.g., infectious, dystrophic, metabolic, toxic or drug-induced myopathies). * Cognitive impairment. * Not able or willing to give informed consent. * Age \<18 years. * Current incarceration There are no gender or ethnic restrictions to enrollment in the study. HIV is not an exclusion for this study for the two following reasons: * It has no impact on study procedures or tests. * HIV may be one of the viral risk factors we are investigating.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adult polymyositis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Madigan Army Medical Center

    Tacoma, Washington, 98431, United States

  • Miami VA Healthcare System

    Miami, Florida, 33125, United States

  • NIEHS Clinical Research Unit (CRU)

    Research Triangle Park, North Carolina, 27709, United States

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

  • Naval Medical Center, Portsmouth

    Portsmouth, Virginia, 23708, United States

  • VA Pittsburgh Healthcare Sys.

    Pittsburgh, Pennsylvania, United States

  • Walter Reed National Medical Center

    Bethesda, Maryland, 20301, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.